These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 16828169

  • 1. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
    Guan Y, Shindler KS, Tabuena P, Rostami AM.
    J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
    [Abstract] [Full Text] [Related]

  • 2. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis.
    Shindler KS, Guan Y, Ventura E, Bennett J, Rostami A.
    Mult Scler; 2006 Oct; 12(5):526-32. PubMed ID: 17086896
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
    Sättler MB, Diem R, Merkler D, Demmer I, Boger I, Stadelmann C, Bähr M.
    Exp Neurol; 2005 May; 193(1):163-71. PubMed ID: 15817275
    [Abstract] [Full Text] [Related]

  • 4. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 May; 22():1503-1513. PubMed ID: 28050123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.
    Shindler KS, Ventura E, Dutt M, Rostami A.
    Exp Eye Res; 2008 Sep; 87(3):208-13. PubMed ID: 18653182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
    Qi X, Sun L, Lewin AS, Hauswirth WW, Guy J.
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
    [Abstract] [Full Text] [Related]

  • 9. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
    Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
    [Abstract] [Full Text] [Related]

  • 10. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.
    Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK.
    J Exp Med; 2003 May 05; 197(9):1073-81. PubMed ID: 12732654
    [Abstract] [Full Text] [Related]

  • 11. Building different mouse models for human MS.
    Bettelli E.
    Ann N Y Acad Sci; 2007 Apr 05; 1103():11-8. PubMed ID: 17376825
    [Abstract] [Full Text] [Related]

  • 12. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
    Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS.
    Invest Ophthalmol Vis Sci; 2010 Mar 05; 51(3):1439-45. PubMed ID: 19892867
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.